Celularity Inc.
CELU
$1.66
-$0.01-0.60%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 225.94% | 182.02% | 109.81% | 26.68% | -20.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 225.94% | 182.02% | 109.81% | 26.68% | -20.93% |
| Cost of Revenue | 48.06% | 11.20% | -11.27% | -18.56% | -38.91% |
| Gross Profit | 887.40% | 20,190.63% | 1,171.63% | 499.70% | 933.51% |
| SG&A Expenses | -1.65% | -11.52% | -20.20% | -23.39% | 10.92% |
| Depreciation & Amortization | -11.99% | -3.88% | 0.23% | 0.00% | 0.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.43% | -35.32% | -44.02% | -40.30% | -30.32% |
| Operating Income | 59.00% | 62.74% | 61.45% | 48.42% | 31.55% |
| Income Before Tax | 80.68% | -36.36% | -1,281.78% | -1,481.80% | -1,171.88% |
| Income Tax Expenses | -23.08% | 350.00% | -23.08% | -23.08% | -35.00% |
| Earnings from Continuing Operations | 80.68% | -36.38% | -1,283.03% | -1,483.14% | -1,170.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.68% | -36.38% | -1,283.03% | -1,483.14% | -1,170.19% |
| EBIT | 59.00% | 62.74% | 61.45% | 48.42% | 31.55% |
| EBITDA | 64.07% | 67.49% | 65.59% | 51.63% | 33.73% |
| EPS Basic | 84.65% | -20.33% | -733.61% | -1,992.95% | -626.18% |
| Normalized Basic EPS | 80.80% | 85.76% | 65.98% | 38.59% | 7.89% |
| EPS Diluted | 85.21% | -10.65% | -1,340.00% | -30,504.32% | -539.92% |
| Normalized Diluted EPS | 79.85% | 84.97% | 63.72% | 35.13% | 11.19% |
| Average Basic Shares Outstanding | 26.72% | 30.97% | 31.95% | 27.29% | 24.04% |
| Average Diluted Shares Outstanding | 19.60% | 21.65% | 19.90% | 15.20% | 26.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |